Analysis reveals the impact of genomic surveillance on infectious diseases in West Africa, suggesting the need for ethical governance of gene-drive technologies.
In recent times, West Africa has emerged as both a critical frontline and experimental ground for global infectious disease surveillance. This study examines the evolution of genomic surveillance in the region, with a focus on the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) as a continental leader in outbreak response and capacity building. Drawing on case studies of Ebola, COVID-19, and Lassa fever, we explore how ACEGID’s strategic innovations, spanning logistics, data sharing, and human resource development have shaped a resilient regional framework. We interrogate the ethical and political dimensions of genomic data sovereignty, highlighting tensions between local benefits and global collaboration. The review also evaluates emerging gene-drive technologies, particularly CRISPR-based approaches targeting vector-borne diseases, assessing their scientific potential, governance challenges, and socio-political implications within West Africa. Finally, we propose a conceptual model integrating real-time pathogen genomics with adaptive gene-drive interventions, while outlining policy recommendations for sustainable, African-led genomic stewardship. By synthesizing lessons from ACEGID’s operational model, we argue for a genomic sovereignty paradigm that balances innovation with equity, and technology with public trust.
No takes yet. Share an insight, caveat, or question.
EO et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: